Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Via Venezian 21, 20133 Milano, Italy.
Molecules. 2023 Feb 16;28(4):1907. doi: 10.3390/molecules28041907.
Chiral diamines based on an 8-amino-5,6,7,8-tetrahydroquinoline backbone, known as CAMPY (), or the 2-methyl substituted analogue Me-CAMPY () were employed as novel ligands in Cp* metal complexes for the ATH of a series of substituted dihydroisoquinolines (DHIQs), known for being key intermediates in the synthesis of biologically active alkaloids. Different metal-based complexes were evaluated in this kind of reaction, rhodium catalysts, and , proving most effective both in terms of reactivity and enantioselectivity. Although modest enantiomeric excess values were obtained (up to 69% in the case of substrate ), a satisfactory quantitative conversion was successfully fulfilled even in the case of the most demanding hindered substrates when La(OTf) was used as beneficial additive, opening up the possibility for a rational design of novel chiral catalysts alternatives to the Noyori-Ikariya (arene)Ru(II)/TsDPEN catalyst.
基于 8-氨基-5,6,7,8-四氢喹啉骨架的手性二胺,称为 CAMPY(),或 2-甲基取代类似物 Me-CAMPY(),被用作新型配体用于 Cp*金属配合物中,以实现一系列取代的二氢异喹啉(DHIQs)的 ATH,这些 DHIQs是生物活性生物碱合成中的关键中间体。在这种反应中评估了不同的基于金属的配合物,铑催化剂,和,在反应活性和对映选择性方面都证明是最有效的。尽管获得的对映体过量值适中(在底物的情况下最高可达 69%),但当使用 La(OTf)作为有益添加剂时,即使是最具挑战性的受阻底物也成功地实现了定量转化,为替代 Noyori-Ikariya(芳烃)Ru(II)/TsDPEN 催化剂的新型手性催化剂的合理设计开辟了可能性。